Enwei Pharmaceutical Co., Ltd. (SHE:301331)
29.38
-0.36 (-1.21%)
Feb 26, 2026, 4:00 PM EST
21.20% (1Y)
| Market Cap | 2.95B +23.2% |
| Revenue (ttm) | 888.64M +14.6% |
| Net Income | 52.06M +47.1% |
| EPS | 0.52 +49.9% |
| Shares Out | 101.08M |
| PE Ratio | 56.04 |
| Forward PE | n/a |
| Dividend | 0.35 (1.20%) |
| Ex-Dividend Date | Jan 8, 2026 |
| Volume | 1,012,500 |
| Average Volume | 2,237,170 |
| Open | 29.69 |
| Previous Close | 29.74 |
| Day's Range | 29.21 - 29.96 |
| 52-Week Range | 21.64 - 39.66 |
| Beta | 0.62 |
| RSI | 51.35 |
| Earnings Date | Apr 27, 2026 |